Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Jan 27, 2013; 5(1): 38-42
Published online Jan 27, 2013. doi: 10.4254/wjh.v5.i1.38
Published online Jan 27, 2013. doi: 10.4254/wjh.v5.i1.38
Table 2 Diuretics treatment before and after transjugular intrahepatic portosystemic shunt treatment
| Before TIPS | After TIPS | |
| Any diuretics treatment (n/n) | 13/14 | 10/14 |
| Furosemide dose [n/n, | 12/14 | 3/14 |
| median (range), mg/d] | 80 (40-240) | 200 (40-240) |
| Spironolactone dose [n/n, | 12/14 | 9/14 |
| median (range), mg/d] | 175 (25-200) | 100 (25-200) |
- Citation: Neumann AB, Andersen SD, Nielsen DT, Holland-Fischer P, Vilstrup H, Grønbæk H. Treatment of Budd-Chiari syndrome with a focus on transjugular intrahepatic portosystemic shunt. World J Hepatol 2013; 5(1): 38-42
- URL: https://www.wjgnet.com/1948-5182/full/v5/i1/38.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i1.38